Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.22.2.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Significant Accounting Policies  
Summary of total cash balances

​

​

​

​

​

​

​

​

​

​

Successor

​

    

June 30, 2022

    

December 31, 2021

Unrestricted

​

$

63,145,379

​

$

140,477,586

Restricted

​

 

753,920

​

 

356,286

Total Cash Balances

​

$

63,899,299

​

$

140,833,872

​

​

​

​

​

​

​

Predecessor

​

    

June 30, 2021

Unrestricted

​

$

16,322,893

Restricted

​

 

223,872

Total Cash Balances

​

$

16,546,765

Summary of sources (by product type) from which the Company's revenues are derived

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Successor

​

​

Predecessor

 

​

 

​

​

​

​

 

Three Months Ended

​

​

​

​

​

Three Months Ended

​

​

​

​

June 30, 2021

​

​

​

Revenue Type

    

June 30, 2022

    

% of Total

    

    

(As Restated)

    

% of Total

​

Capitated Revenue

​

$

267,102,466

 

99.1

%  

​

$

141,560,867

 

97.9

%

Other Patient Service Revenue:

​

 

  

 

  

​

​

 

  

 

  

​

Clinical Fees & Insurance Revenue

​

 

264,624

 

0.1

%  

​

 

1,286,863

 

0.9

%

Shared Risk Revenue

​

 

55,154

 

0.0

%  

​

 

202,011

 

0.1

%

Care Coordination / Management Fees

​

 

762,067

 

0.3

%  

​

 

971,605

 

0.7

%

Incentive Fees

​

 

1,269,660

 

0.5

%  

​

 

565,098

 

0.4

%

Total Other Patient Service Revenue

​

 

2,351,505

 

0.9

%  

​

 

3,025,577

 

2.1

%

Total Revenue

​

$

269,453,971

 

100

%  

​

$

144,586,444

 

100

%

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Successor

​

​

Predecessor

 

​

 

​

​

​

  

  

Six Months Ended

​

​

​

​

​

Six Months Ended

​

​

​

​

June 30, 2021

​

​

​

Revenue Type

    

June 30, 2022

    

% of Total

​

    

(As Restated)

    

% of Total

​

Capitated Revenue

​

$

536,787,281

 

98.9

%  

​

$

290,525,057

 

98.2

%

Other Patient Service Revenue:

​

 

​

​

  

​

​

 

  

 

​

​

Clinical Fees & Insurance Revenue

​

 

2,146,877

 

0.4

%  

​

 

2,108,627

 

0.7

%

Shared Risk Revenue

​

 

55,154

 

0.0

%  

​

 

202,011

 

0.1

%

Care Coordination / Management Fees

​

 

2,683,173

 

0.5

%  

​

 

1,848,400

 

0.6

%

Incentive Fees

​

 

1,325,820

 

0.2

%  

​

 

1,200,291

 

0.4

%

Total Other Patient Service Revenue

​

 

6,211,024

 

1.1

%  

​

 

5,359,329

 

1.8

%

Total Revenue

​

$

542,998,305

 

100

%  

​

$

295,884,386

 

100

%

Summary of health plans from which the Company has a concentration of revenue that is 10.0%, or more

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Successor

​

​

Predecessor

 

​

 

​

​

​

  

  

Three Months Ended

​

​

​

​

​

Three Months Ended

​

​

​

​

June 30, 2021

​

​

​

Plan Name

    

June 30, 2022

    

% of Total

    

    

(As Restated)

    

% of Total

​

Health Plan C

​

$

54,392,897

 

20.2

%  

​

$

18,412,847

 

12.7

%

Health Plan B

​

 

45,818,789

 

17.0

%  

​

 

33,449,667

 

23.2

%

Health Plan A

​

 

48,047,307

 

17.8

%  

​

 

39,119,191

 

27.1

%

Health Plan D

​

 

36,013,196

 

13.4

%  

​

 

27,231,621

 

18.8

%

All Other

​

 

85,181,782

 

31.6

%  

​

 

26,373,118

 

18.2

%

Total Revenue

​

$

269,453,971

 

100

%  

​

$

144,586,444

 

100

%

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Successor

​

​

Predecessor

 

​

 

​

​

​

​

 

Six Months Ended

​

​

​

​

​

Six Months Ended

​

​

​

​

June 30, 2021

​

​

​

Plan Name

    

June 30, 2022

    

% of Total

  

    

(As Restated)

    

% of Total

​

Health Plan C

​

$

109,714,073

 

20.2

%  

​

$

37,693,084

 

12.7

%

Health Plan B

​

 

93,838,172

 

17.3

%  

​

 

67,034,039

 

22.7

%

Health Plan A

​

 

93,285,372

 

17.2

%  

​

 

77,813,676

 

26.3

%

Health Plan D

​

 

72,876,157

 

13.4

%  

​

 

54,925,880

 

18.6

%

All Other

​

 

173,284,531

 

31.9

%  

​

 

58,417,707

 

19.7

%

Total Revenue

​

$

542,998,305

 

100

%  

​

$

295,884,386

 

100

%

Summary of settlement receivables (health plan surpluses) and settlement payables (health plan deficits), by health plan, by year

​

​

​

​

​

​

​

​

​

    

Health Plan Receivables

​

​

Successor

​

​

June 30, 2022

​

December 31, 2021

Health Plan A

​

$

4,296,896

​

$

4,695,712

Health Plan B

​

 

24,371,497

​

 

15,473,828

Health Plan C

​

 

32,543,742

​

 

1,380,752

Health Plan D

​

 

13,749,578

​

 

6,651,586

Health Plan E

​

 

517,654

​

 

2,439,046

Health Plan F

​

 

1,435,258

​

 

2,925,751

Health Plan G

​

 

19,890

​

 

239,375

Health Plan H

​

 

3,795,423

​

 

2,185,619

Health Plan I

​

 

1,504,353

​

 

1,134,750

Health Plan J

​

 

317,704

​

 

149,915

Health Plan K

​

 

666,312

​

 

2,705,147

Health Plan L

​

 

260,317

​

 

899,560

Health Plan M

​

 

3,310,581

​

 

1,747,116

Health Plan N

​

 

1,596,377

​

 

974,092

Health Plan O

​

 

2,696,375

​

 

666,291

Health Plan P

​

 

415,688

​

 

106,162

Health Plan Q

​

 

351,090

​

 

61,990

Health Plan R

​

 

4,426,655

​

 

3,578,682

Health Plan S

​

 

600,639

​

 

—

Health Plan T

​

 

2,198,285

​

 

2,175,324

Health Plan U

​

 

723,797

​

 

60,306

Health Plan W

​

 

8,299

​

 

—

Total Health Plan Receivables

​

$

99,806,410

​

$

50,251,004

​

​

​

​

​

​

​

​

​

    

Health Plan Settlement Payables

​

​

Successor

​

​

June 30, 2022

​

December 31, 2021

Health Plan A

​

$

109,085

​

$

—

Health Plan B

​

 

11,700,274

​

 

11,700,274

Health Plan D

​

 

—

​

 

3,882,250

Health Plan F

​

 

5,144,469

​

 

6,085,425

Health Plan G

​

 

885,194

​

 

776,164

Health Plan I

​

 

(147,868)

​

 

(215,626)

Health Plan O

​

 

16,552

​

 

(39,151)

Health Plan U

​

 

226,209

​

 

226,209

Health Plan V

​

 

88,480

​

 

133,149

Total Health Plan Settlement Payables

​

$

18,022,395

​

$

22,548,694